SITC Resource Library

Immunotherapy for the Treatment of Melanoma for Health Care Professionals: Patient Resource Guide 

12-29-2016 15:29

For decades, doctors and researchers have conducted clinical trials to further progress in the clinical implementation of tumor immunotherapy. Former President Jimmy Carter's success with immunotherapy for advanced melanoma and Vice President Joe Biden's Cancer Moonshot Initiative have brought this new treatment type, as well as cancer treatments in general, into the spot light for the general public. As a result, health care professionals may experience a spike in inquiries about this new treatment. Several Immunotherapy agents are now available for melanoma. Although surgery often remains the first line of treatment, especially for early-stage melanomas, the U.S. Food and Drug Administration is rapidly approving new immunotherapy medications for advanced melanoma. This guide, published by Patient Resource Publishing in partnership with the Society for Immunotherapy of Cancer (SITC), outlines available immunotherapy options for melanoma, the role of the immune system in cancer treatment, and what to expect while undergoing treatment. This resource also lists ongoing melanoma immunotherapy clinical trials (as of October 2016).

#PrimaryCarePhysician#SkinCancers#AlliedHealth#2016#Pharmacist#Clinician
#RegisteredNurse#Oncologist#PatientResourceGuides#SITC#Melanoma#Cytokines
#ImmuneCheckpointInhibitors#Vaccines#ClinicalTrials#SideEffects#AdverseEvents
#Bcells#Tcells#Antigenpresentingcells#MonoclonalAntibodies#OncolyticViruses
#Ipilimumab#Nivolumab#Pembrolizumab#Imiquimod#CoverageandReimbursement
#EmergencyPhysician

Statistics
0 Favorited
132 Views
1 Files
0 Shares
319 Downloads
Attachment(s)
pdf file
ImmunotherapyforMelanomaProfessionaledition.pdf   1.07 MB   1 version
Uploaded - 01-03-2018